Not registered yet? Get a free account.

Sign Up
search icon cancel icon

AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED

Active
Updated: 28 Jun 2025

The company provides contract research services, with a focus on new drug delivery systems, and conducts clinical trials on behalf of its clients.

Aizant Drug Research Solutions Private Limited, is an unlisted private company incorporated on 22 November, 2005. It is classified as a private limited company and is located in , . It's authorized share capital is INR 26.00 cr and the total paid-up capital is INR 24.69 cr.

Read more

Subscription Plans
Industry and products
Manufacturing of Pharmaceuticals
  • Comprehensive solutions for preformulation, analytical development, and novel drug delivery products., formulation development of conventional
Company size
Auth Capital
₹ 26.0 Cr
Paidup Capital
₹ 24.7 Cr
Revenue
₹ 200-300 cr
Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue
46.74%
₹ GET PRO
EBITDA
66.71%
₹ GET PRO
Net Profit
88.14%
₹ GET PRO
Networth
26.37%
₹ GET PRO
Borrowings
24.78%
₹ GET PRO
Assets
18.86%
₹ GET PRO
Gross Margin
-3.39
GET PRO %
Operating Margin
3.16
GET PRO %
Net Profit Margin
3.72
GET PRO %
Return on Equity
6.86
GET PRO %
ROCE
9.05
GET PRO %
Debt to Equity
-
GET PRO
Sales
Mar 2024
Net worth
Mar 2024

Locations

indian flag India (5)
State Type Address

location icon Locations on Map

Map placeholder

People

Designation Name DIN/PAN Tenure
Director Tirunelveli Padmanabhan Devarajan 03473633 8 years
Managing Director Varma Srinivasa Rajasekara Rudraraju
Shareholder
01661426 20 years
Director Sanjeev Kumar Sethi 02168682 1 years
Director Rudraraju Sneha 09683892 1 years

Financial Highlights

Financials upto March 2024 available in Tofler Pro
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Gross margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin GET PRO GET PRO GET PRO GET PRO GET PRO
Networth
Borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Debt to equity GET PRO GET PRO GET PRO GET PRO GET PRO
Current ratio GET PRO GET PRO GET PRO GET PRO GET PRO
ROE GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
WC days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

%

Financials upto March 2024 available in Tofler Pro

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital GET PRO GET PRO GET PRO GET PRO GET PRO
Reserves GET PRO GET PRO GET PRO GET PRO GET PRO
Borrowings + GET PRO GET PRO GET PRO GET PRO GET PRO
Long term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Short term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Trade payables + GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
Other liabilities + GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Other current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Total liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Tangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
CWIP GET PRO GET PRO GET PRO GET PRO GET PRO
Intangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
LT loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Current assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Inventories GET PRO GET PRO GET PRO GET PRO GET PRO
Trade receivables GET PRO GET PRO GET PRO GET PRO GET PRO
Cash and cash equivalents GET PRO GET PRO GET PRO GET PRO GET PRO
ST loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total assets GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Total assets

Charges on assets

Bank wise
Charges
1

The Karur Vysya Bank Limited

No. of Loans: 1

Total Amount : 12.8 cr

2

HDFC Bank Limited

No. of Loans: 1

Total Amount : 5.0 cr

3

State Bank of India

No. of Loans: 1

Total Amount : 2.9 cr

chart icon

Charges

The Karur Vysya Bank Limited
HDFC Bank Limited
State Bank of India

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
KURU CONSULTANTS PRIVATE LIMITED
Strike Off
1.0 L 1 Andhra Pradesh
INCILIA THERAPEUTICS PRIVATE LIMITED
Active
1.0 L 1 Telangana
VIVOZANT BIOSCIENCES PRIVATE LIMITED
Strike Off
0.0 1 Telangana
AIZANT PHARMACEUTICALS PRIVATE LIMITED
Active
1.0 L 1 Andhra Pradesh
SANATIVE THERAPEUTICS PRIVATE LIMITED
Strike Off
1.0 L 1 Telangana
AIZEN SIM6 PRIVATE LIMITED
Active
1.0 L 1 Telangana
AIZEN ALGO PRIVATE LIMITED
Active
2.1 Cr 2 Telangana
AGILA SPECIALTIES PRIVATE LIMITED
Amalgamated
18.3 Cr 1 Telangana
COUNCIL FOR HEALTHCARE AND PHARMA FRONT
Active
1.0 L 1 Delhi
ONCO THERAPIES LIMITED
Amalgamated
2.4 Cr 1 Telangana
SMV PROMOTERS LLP
Active
1.0 L 1 ry
SANDOR LIFE SCIENCES PRIVATE LIMITED
Active
10.7 Cr 1 Telangana
ALNICHE LIFESCIENCES PRIVATE LIMITED
Active
1.3 L 1 Delhi
PHASORZ TECHNOLOGIES PRIVATE LIMITED
Active
58.1 Cr 1
MALLADI DRUGS AND PHARMACEUTICALS LIMITED
Active
63.9 Cr 1
ANKURA MEDICAL & RESEARCH CENTRE PRIVATE LIMITED
Active
5.7 Cr 1

Tofler Score

score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Registered Details

CIN

U24239TG2005PTC048133

PAN

AABCI5229B

Incorporation

2005, 19.6 years

Company Email

accounts@aizant.com

Paid up Capital

₹ 24.7 Cr

Authorised Capital

₹ 26.0 Cr

AGM

Sep 2024

Type

Private
Others

FAQ - AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED

What is the incorporation date of AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED?

plus icon

The incorporation date of AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED is 22 November, 2005

What is the authorized share capital of AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED?

plus icon

The authorized share capital of AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED is INR ₹ 26.0 Cr.

What is the paid-up capital of AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED?

plus icon

The paid-up capital of AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED is INR ₹ 24.7 Cr.

What is the registered address of AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED?

plus icon

The registered address of AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED is Sy No.172 /173, Apparel Park Road, Dulapally Vil. Dundigal Gandimaisamma Mdl, Medchal - Ma, lkajgiri, Rangareddi, Hyderabad, Telangana, India, 500100 - 500100

What is the CIN number of AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED?

plus icon

The CIN number of AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED is U24239TG2005PTC048133.

Smart Suggestions

  • Uttar Pradesh
  • Haryana
  • Jammu & Kashmir
  • Punjab
  • Goa
  • Madhya Pradesh
  • Kerala
  • Gujarat
  • Andhra Pradesh
  • Telangana
  • Blog Categories
  • Top Blog post
  • Financial Resources
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More